[FeIIICl(TMPPH2)][FeIIICl4]2: A Stand-Alone Molecular Nanomedicine That Induces High Cytotoxicity by Ferroptosis
Molecules · 2024
DOI: 10.3390/molecules29112495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Xiao Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry, Chemical Engineering, and Materials Science, Soochow University, Suzhou 215123, China. Hauptthemen laut MEDLINE: Ferroptosis, Nanomedicine, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation from Guangdong Science and Technology Department of China, Project of Medical Innovation Application Research of Suzhou.
Abstract (Originalsprache)
Developing clinically meaningful nanomedicines for cancer therapy requires the drugs to be effective, safe, simple, cheap, and easy to store. In the present work, we report that a simple cationic Fe(III)-rich salt of [FeIIICl(TMPPH2)][FeIIICl4]2 (Fe-TMPP) exhibits a superior anticancer performance on a broad spectrum of cancer cell lines, including breast, colorectal cancer, liver, pancreatic, prostate, and gastric cancers, with half maximal inhibitory concentration (IC50) values in the range of 0.098–3.97 μM (0.066–2.68 μg mL−1), comparable to the best-reported medicines. Fe-TMPP can form stand-alone nanoparticles in water without the need for extra surface modification or organic-solvent-assisted antisolvent precipitation. Critically, Fe-TMPP is TME-responsive (TME = tumor microenvironment), and can only elicit its function in the TME with overexpressed H2O2, converting H2O2 to the cytotoxic •OH to oxidize the phospholipid of the cancer cell membrane, causing ferroptosis, a programmed cell death process of cancer cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry, Chemical Engineering, and Materials Science, Soochow University, Suzhou 215123, China.
- NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
- Glasgow College UESTC, University of Electronic Science and Technology of China, Chengdu 611731, China.
ORCID-Profile: Wen-Hua Zhang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation from Guangdong Science and Technology Department of China
- Project of Medical Innovation Application Research of Suzhou
Zitieren
APA
Wang, X., Feng, J. H., Zeng, C. M., Zhang, Z. S., Cao, F. L., Zhang, W. H., Chen, J. X., & Young, D. J. (2024). [FeIIICl(TMPPH2)][FeIIICl4]2: A Stand-Alone Molecular Nanomedicine That Induces High Cytotoxicity by Ferroptosis. Molecules. https://doi.org/10.3390/molecules29112495
Vancouver
Wang X, Feng JH, Zeng CM, Zhang ZS, Cao FL, Zhang WH, et al. [FeIIICl(TMPPH2)][FeIIICl4]2: A Stand-Alone Molecular Nanomedicine That Induces High Cytotoxicity by Ferroptosis. Molecules. 2024. doi:10.3390/molecules29112495
BibTeX
@article{Wang2024,
author = {Wang, Xiao and Feng, Jia-Hao and Zeng, Chun-Mei and Zhang, Ze-Sheng and Cao, Feng-Lin and Zhang, Wen-Hua and Chen, Jin-Xiang and Young, David J},
title = {[FeIIICl(TMPPH2)][FeIIICl4]2: A Stand-Alone Molecular Nanomedicine That Induces High Cytotoxicity by Ferroptosis},
journal = {Molecules},
year = {2024},
doi = {10.3390/molecules29112495}
}
EUVIMED